Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| 1 |
Broadcom
AVGO
|
$2.09B |
| 2 |
Mastercard
MA
|
$2.06B |
| 3 |
UnitedHealth
UNH
|
$1.3B |
| 4 |
Coca-Cola
KO
|
$1.17B |
| 5 |
Marsh & McLennan
MMC
|
$1.1B |
Top Sells
| 1 |
Alphabet (Google) Class A
GOOGL
|
$1.55B |
| 2 |
Apple
AAPL
|
$1.51B |
| 3 |
JPMorgan Chase
JPM
|
$1.34B |
| 4 |
General Dynamics
GD
|
$1.25B |
| 5 |
Wells Fargo
WFC
|
$1.17B |
Sector Composition
| 1 | Technology | 21.49% |
| 2 | Healthcare | 18.42% |
| 3 | Financials | 15.97% |
| 4 | Consumer Discretionary | 9.49% |
| 5 | Industrials | 8.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
Amdocs
DOX
$9.41B
| $243M | 0.05% |
2,651,582
-28,840
| -1% | -$2.64M |
|
302
Vaxcyte
PCVX
$4.1B
| $242M | 0.05% |
6,416,930
+1,972,918
| +44% | +$74.5M |
|
303
C.H. Robinson
CHRW
$15.2B
| $241M | 0.05% |
2,351,997
-547,553
| -19% | -$56.1M |
|
304
argenx
ARGX
$43.6B
| $240M | 0.05% |
406,204
-18,770
| -4% | -$11.1M |
|
305
Akero Therapeutics
AKRO
$3.74B
| $240M | 0.05% |
5,936,240
-1,440,721
| -20% | -$58.3M |
|
306
Amicus Therapeutics
FOLD
$2.43B
| $238M | 0.05% |
29,200,617
+738,623
| +3% | +$6.03M |
|
307
Enphase Energy
ENPH
$4.84B
| $237M | 0.05% |
3,825,027
-88,742
| -2% | -$5.51M |
|
308
Flowserve
FLS
$7.02B
| $237M | 0.05% |
4,856,358
+248,273
| +5% | +$12.1M |
|
309
CarGurus
CARG
$3.43B
| $235M | 0.05% |
8,052,180
+906,830
| +13% | +$26.4M |
|
310
Micron Technology
MU
$133B
| $234M | 0.05% |
2,689,843
-293,185
| -10% | -$25.5M |
|
311
Stifel
SF
$11.8B
| $234M | 0.04% |
2,478,267
-110,697
| -4% | -$10.4M |
|
312
Cinemark Holdings
CNK
$2.97B
| $233M | 0.04% |
9,346,856
+1,066,225
| +13% | +$26.5M |
|
313
Neurocrine Biosciences
NBIX
$13.8B
| $232M | 0.04% |
2,097,981
+640,556
| +44% | +$70.8M |
|
314
Vanguard S&P 500 ETF
VOO
$720B
| $231M | 0.04% |
449,785
+112,521
| +33% | +$57.8M |
|
315
Crinetics Pharmaceuticals
CRNX
$3.14B
| $231M | 0.04% |
6,891,397
-59,170
| -0.9% | -$1.98M |
|
316
Shake Shack
SHAK
$4.27B
| $231M | 0.04% |
2,620,375
+1,383,999
| +112% | +$122M |
|
317
WESCO International
WCC
$10.7B
| $230M | 0.04% |
1,481,370
+369,381
| +33% | +$57.4M |
|
318
New York Times
NYT
$9.74B
| $227M | 0.04% |
4,583,107
-940,219
| -17% | -$46.6M |
|
319
CRH
CRH
$74.7B
| $227M | 0.04% |
2,618,135
-128,824
| -5% | -$11.2M |
|
320
Goodyear
GT
$2.4B
| $226M | 0.04% |
24,489,875
-285,650
| -1% | -$2.64M |
|
321
Glaukos
GKOS
$5.5B
| $225M | 0.04% |
2,290,790
+131,251
| +6% | +$12.9M |
|
322
Houlihan Lokey
HLI
$14B
| $225M | 0.04% |
1,395,148
-104,531
| -7% | -$16.9M |
|
323
Axalta
AXTA
$6.77B
| $223M | 0.04% |
6,730,406
+132,234
| +2% | +$4.39M |
|
324
Nextracker
NXT
$9.95B
| $221M | 0.04% |
5,237,833
+1,890,445
| +56% | +$79.7M |
|
325
Hyatt Hotels
H
$13.8B
| $221M | 0.04% |
1,800,639
+116,813
| +7% | +$14.3M |
|